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R = 0.25), whereas controls showed no correlation (R = 0.0) (see
Data S1: Supporting information).
Along with these results, higher antimelanocyte antibody and
LPO levels in AV patients signify equal contribution of both oxi-
dative stress and autoimmunity in disease progression. Various
antioxidant enzymes can be induced by inflammatory cytokines
such as TNF-a and IFN-c, which in turn increase ROS levels in
vitiligo patients (18). Our recent studies also showed increased
transcript levels of SOD2, SOD3 (13), TNFA (19), TNFB (20) and
IFNG (21) in vitiligo patients. There are reports showing the gen-
eration of free radicals during melanogenesis which hydroxylate
tyrosinase and other proteins, thereby increasing their antigenicity
(22,23). Elassiuty et al., showed upregulation of heme oxygenase-1
in patients’ melanocytes due to high oxidative stress (24). The
build-up of ROS along with possible immune system defects
allows for the inappropriate autoimmune response against mela-
nocytes. ROS are involved in specific early events in T-cell activa-
tion and antioxidants are involved in reducing T-cell proliferation
(25). We showed decreased regulatory T cells and CD4+/CD8+
ratio in GV patients, which were positively correlated with disease
onset and progression (26). High oxidative stress can lead to the
breakdown of self-tolerance by releasing plethora of sequestered
autoantigens and generation of neoantigens (1).
Conclusion
For the first time, our study suggests that oxidative stress may be
the initial triggering event to precipitate vitiligo in Gujarat popu-
lation, which is then exacerbated by contribution of autoimmune
factors together with oxidative stress.
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Abstract: Epidermal Langerhans cells (LCs) and dermal dendritic
cells (dDCs) capture cutaneous antigens and present them to
T-cells in lymph nodes (LNs). The function of LCs and Langerin+
dDCs was extensively studied in the mouse, but their anatomical
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repartition is unknown. Here, we found LCs in back skin,
footpads and tail skin of C57BL/6, BALB/c, 129/Sv and CBA/J
mice. Langerin+ dDCs were readily observed in back skin of all
strains, but only in footpads and tail of BALB/c and CBA/J mice.
Similarly, while LCs were equally present in all LNs and strains,
Langerin+ dDCs were found in popliteal LNs (draining footpads)
only in BALB/c and CBA/J mice. The sciatic LNs, which we
identified as the major tail-draining lymphoid organ, were devoid
of Langerin+ dDCs in all strains. Thus, functionally different DCs
reside in different skin areas, with variations among mouse
strains, implying a potential impact on the cutaneous immune
reaction.
Key words: dermal dendritic cells – footpad skin – Langerhans cells –
skin-draining lymph nodes – tail skin
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Background
Although they represent only a small proportion of total skin
DCs, epidermal Langerhans cells (LCs) and Langerin+ dermal den-
dritic cells (dDCs) have been the subject of many functional stud-
ies in the mouse, discrepancies still exist as to their functional
specialisation (1–6). LCs often appear tolerogenic, while Langerin+
dDCs have a critical role in cross-presentation of skin-derived
antigens and type 1 T helper responses (3,5,7–9).
Questions addressed
The anatomical repartition (10,11) and strain-associated variations
of Langerin+ DC subsets have not been thoroughly investigated,
although such differences could have an important impact on the
interpretation of results and better understanding of skin-specific
immune responses. We analysed Langerin+ DC subsets in back
skin, footpads and tail and in corresponding skin-draining LNs of
C57BL/6, BALB/c, 129/Sv and CBA/J mouse strains.
Experimental design
Animals
C57BL/6, CBA/J, 129/Sv and BALB/c mice (Charles River Labora-
tories France) were housed in specific pathogen-free conditions,
and all experiments were carried out in conformity to the animal
bioethics legislation.
Preparation of skin and LN cell suspensions
Back skin, footpad and tail skin as well as inguinal, popliteal,
sciatic and mesenteric LNs were collected. Small pieces of
tissues were incubated at 37°C in DMEM medium supple-
mented with 2% foetal calf serum (FCS; PAN-Biotech, Aiden-
bach, Germany), 1 mg/ml collagenase D, 1 mg/ml dispase II,
50 lg/ml DNAse I (all enzymes from Roche Diagnostics,
Meylan, France) for 1 h (LNs) or 2 h (skin) on a shaker. 5 mM
EDTA was added to stop enzymatic digestion, and cells were
filtered through a 40 lm cell strainer (BD Biosciences).
Flow cytometry
All reactions were performed at 4°C for 20 min in PBS comple-
mented with 2% FCS and 2.5 mM EDTA. Fc-receptors were blocked
with 5 lg/ml CD16/CD32 antibody (2.4G2, BD, San Diego, CA,
USA). Dead cells were excluded by labelling with Fixable Viability
Dye (eBioscience, Frankfurt, Germany) in PBS for 30 min. Surface
stainings were performed with 1 lg/ml of the following reagents:
streptavidin-APC, anti-CD103-PE or –PerCP-Cy5.5 (M290),
anti-CD11c-PerCP-Cy5.5 (N418) or –PE-Cy7 (HL3), anti-CD3-PE
(145-2C11), anti-CD45-APC (30-F11; all from BD) and anti-
CCR7-biotinylated (4B12, eBioscience) or their isotype controls.
Cells were fixed, permeabilised (Cytofix/Cytoperm, BD) and labelled
with 1 lg/ml anti-Langerin-FITC (929F3.01, Dendritics, Lyon,
France). Flow cytometry was performed on a Gallios (Beckman-
Coulter, Fullerton, CA, USA) and analysed with FlowJo (Treestar,
Ashland, OR, USA).
Results
CD45+ CD11c+ skin DCs include CD103 EpCAMhigh Langerin+
LCs and CD103+ EpCAMlow Langerin+ dDCs (1,2,7,9,12,13). We
found LCs in all skin areas and mice studied (Fig. 1a), but their
proportion relative to CD11c+ DCs varied with their location
(Fig. 1b). LCs were abundant in back skin and footpads, but rare
in tail. The low proportion of LCs in tail was confirmed by
immunofluorescence on epidermal sheets (Figure S2a,b; 10). Com-
pared to LCs, the percentage of Langerin+ dDCs was lower
(Fig. 1a), with a manifest variability across skin locations and
mouse strains (Fig. 1c). Indeed, while this DC subset was consis-
tently found in back skin of all strains tested, it was only detect-
able in footpads of BALB/c and to a lesser extent of CBA/J mice.
Langerin+ dDCs were missing from tail skin in all strains.
(a)
(b) (c)
Figure 1. Skin dendritic cell (DC) subset composition varies according to the
localisation and mouse strains. (a) Single-cell suspensions were prepared from
back, footpad and tail skin of C57BL/6, BALB/c, 129/Sv and CBA/J mice and
analysed by flow cytometry. CD11c+ CD3 DCs were selected among viable
CD45+ cells. Additional gating of Langerin/+ CD3 allowed to further eliminate
T-cells with low levels of CD3. The corresponding isotype controls are shown in
Figure S1a. Red gates highlight a percentage of Langerin+ CD103+ cells above
1%. Panels (b) and (c) present the compiled percentage data of both skin DC
subsets in different skin areas and across the mouse strains, respectively (mean of
two experiments, n ≥ 4 mice in each condition; significant values: *<0.05;
***<0.0001). Dashed red line indicates the 1% threshold below which staining
was considered as background. Percentages of Langerin- CD103+ dDCs are
available in Figure S4a.
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Immunofluorescence staining confirmed the scarcity of Langerin+
dDCs in footpads of C57BL/6 but their presence in BALB/c mice
(Figure S2c).
Variations in thickness and hairiness might impede uniform
enzymatic digestion of the different skin areas. Because they are
migratory, skin DCs can be isolated from skin-draining lymph
nodes (LNs). However, the LNs that drain the tail remain unclearly
defined (14). We identified the sciatic LN as a major draining site
for a coloured dye injected into the tail (Figure S3a). Mice with
skin-draining LN hypertrophy (15,16) also had enlarged sciatic LNs
(Figure S3b). Tg(Grm1)EPv mice that spontaneously develop mela-
nomas on the tail (17) present with melanin-loaded sciatic LNs
(Figure S3c). Finally, tail skin inflammation triggered by the TLR7
agonist imiquimod (18) or the irritant chemical dibutylphthalate
(19) induced emigration of LCs into sciatic LNs (Figure S3d,e).
We therefore studied inguinal (draining back skin), popliteal
(footpads) and sciatic (tail) LNs, using mesenteric (intestine) LNs
as a control. Skin-derived DCs were distinguished from LN-resident
DCs by the expression of the chemokine receptor CCR7 that
guides them upon emigration (Fig. 2a; 20). LCs were found in all
skin-draining LNs (Fig. 2b), but the percentage of Langerin+
dDCs varied greatly and was in line with our analysis at skin level
(Fig. 2c). They were clearly present in inguinal LNs of all strains,
in popliteal LNs of BALB/c and CBA/J mice only, and were totally
absent from sciatic LNs in all strains.
Conclusions
While LCs are present in all skin types of all mouse strains, the dis-
tribution of Langerin+ dDCs appears site- and strain-specific. There
was an absence of Langerin+ dDCs from footpads and popliteal
LNs of C57BL/6 mice and 129/Sv and from tail and tail-draining
LNs of all strains. The major tail-draining LNs were identified as
the sciatic LNs based on a number of criteria including mobilisa-
tion by skin inflammation. Even upon skin DC mobilisation, no
Langerin+ dDCs were observed in sciatic LNs. Inefficient hapten
sensitisation on tail skin has been associated with the low density of
LCs in this area (10), but the lack of Langerin+ dDCs might con-
tribute to this hyporesponsiveness (3). A recent report suggested a
complete absence of dDCs from footpads (11), but we found Lang-
erin dDCs in all sites investigated (Figure S4).
Such differences among skin DC subsets are reminiscent of
mouse-strain-specific expression of the endocytic receptor Langer-
in by LN-resident CD8+ DCs and gut DCs (21,22), and by the
variations of plasmacytoid DC numbers linked to genetic
polymorphisms (23,24). Footpads and the tail have a particularly
protective stratum corneum, which might explain why immuno-
surveillance does not necessarily require the highly immunocom-
petent Langerin+ dDCs. Alternatively, a lack of Langerin+ dDCs
could limit immune responses in these areas that are constantly
subject to physical stress.
Our findings strongly encourage side-by-side analyses of human
DC subsets from different skin locations, that is areas exposed to
UV or mechanical stress (25,26), and across ethnic groups. This
may shed light on the frequencies of site-specific dermatitis or
tumor formation in diverse genetic backgrounds. Finally, our
results suggest new means to target specific DC subsets to manip-
ulate the outcome of immunisation (27,28).
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Abstract: Understanding molecular mechanisms of skin ageing is
critical for developing effective anti-ageing strategies. Recently, it
has been suggested that epigenetics maybe be involved in tissue
ageing and age-related diseases; however, the evidence regarding
skin ageing has been very limited. We ran a pilot study in mouse
skin to test whether DNA methyltransferases (Dnmts), DNA
demethylases such as ten-eleven translocation enzymes (Tets) and
DNA methylation of gene promoters change with age by
quantitative RT-PCR and methylated DNA immunoprecipitation
(MeDIP)-chip. We discovered that the expression of Dnmt3a,
Dnmt3b and Tet2 declines significantly with skin ageing. The
genome-wide DNA methylation analysis indicates that both hyper-
methylation and hypomethylation in promoters of genes are taken
place. Functional category of those genes suggests that inhibition
of cell proliferation and activation of immune response are
important adaptations likely induced by skin ageing. These
findings shed new light on epigenetic regulation of skin ageing.
Key words: chromosome loci – DNA methylation – DNA
methyltransferase – gene expression – keratin – skin ageing – ten-eleven
translocation enzyme
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Background
Skin is the first barrier of body protection against environmental
damages, and it is believed that the pace of skin ageing is a conse-
quence of interactions between inherited genetic factors and envi-
ronmental stimuli. The latter mentioned exogenous factors are
assumed to modulate the fate of skin cells, possibly through epige-
netic regulation of gene expression (1,2). Epigenetic regulation is
primarily mediated by histone modification and DNA methyla-
tion. DNA methylation involves the addition/removal of a methyl
group to/from the 5th position of the cytosine pyrimidine ring
and alters gene expression patterns in cells such that phenotype of
cells can be modified accordingly (3). In mammals, DNA methyla-
tion occurs predominantly at promoters and CpG islands and
inversely regulates the gene transcription (4–7). Gene promoter
methylation leads gene silencing and thus phenotypic alterations.
High-throughput analysis of gene and protein expressions in age-
ing skins suggested that dysregulation of gene expression is a com-
mon feature for skin ageing, but the underlying mechanism is
unknown (8–15). Accumulated evidence supports the concept that
DNA methylation change may contribute greatly to age-associated
gene expression deregulation (16–20).
Question addressed
In this study, we asked whether the aberrant DNA methylation
pattern is developed with skin ageing in a mouse cohort.
Experimental design
DBA2 female mouse cohort with ages of young (3 months) and
old (22 months) groups were housed at Yale animal facility. Mice
(a group with 5) were sacrificed, and full thickness skins were dis-
sected according to Yale IACUC approved protocol. DNA/RNA
isolation of skin samples was carried out using Qiagen DNA/RNA
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